Gene therapy increases survival for end-stage head and neck cancer
Wednesday, May 28, 2008 - 12:28
in Health & Medicine
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.